Compare Moderna, Inc. (MRNA) vs Sana Biotechnology Inc (SANA) Price & Performance

Moderna, Inc.Trade

Sana Biotechnology IncTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Sana Biotechnology Inc — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Moderna, Inc. is far larger — about 27× Sana Biotechnology Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.

	MRNA	SANA
Market Cap	$23.60B	$873.84M
Sector	Health	Health
52-Week High	$81.80	$5.92
52-Week Low	$22.36	$2.68
Enterprise Value	$19.70B	$848.03M

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 12 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

SANA

View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.